408 related articles for article (PubMed ID: 28043221)
1. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine.
Hendry AJ; Dey A; Beard FH; Khandaker G; Hill R; Macartney KK
Commun Dis Intell Q Rep; 2016 Dec; 40(4):E470-E474. PubMed ID: 28043221
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
[TBL] [Abstract][Full Text] [Related]
3. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
[TBL] [Abstract][Full Text] [Related]
4. Safety of the Polish BCG-10 Vaccine During a Period of BCG Vaccine Shortage: An Australian Experience.
Wong NX; Buttery J; McMinn A; Azhar Z; Crawford NW
Pediatr Infect Dis J; 2020 Jun; 39(6):e66-e68. PubMed ID: 32150004
[TBL] [Abstract][Full Text] [Related]
5. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
[TBL] [Abstract][Full Text] [Related]
6. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
[TBL] [Abstract][Full Text] [Related]
8. The rate of adverse events following BCG vaccination in Poland.
Krysztopa-Grzybowska K; Paradowska-Stankiewicz I; Lutyńska A
Przegl Epidemiol; 2012; 66(3):465-9. PubMed ID: 23230718
[TBL] [Abstract][Full Text] [Related]
9. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB
Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of adverse events following immunisation: Australia, 2000-2002.
Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
[TBL] [Abstract][Full Text] [Related]
11. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
Dierig A; Tebruegge M; Krivec U; Heininger U; Ritz N;
Vaccine; 2015 Sep; 33(38):4994-9. PubMed ID: 26151543
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
[TBL] [Abstract][Full Text] [Related]
13. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
[TBL] [Abstract][Full Text] [Related]
14. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
[TBL] [Abstract][Full Text] [Related]
15. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
[TBL] [Abstract][Full Text] [Related]
16. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
Szczuka I
Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
[TBL] [Abstract][Full Text] [Related]
17. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
[TBL] [Abstract][Full Text] [Related]
18. Management of adverse reactions to bacille Calmette-Guérin vaccine.
FitzGerald JM
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S75-6. PubMed ID: 11010827
[TBL] [Abstract][Full Text] [Related]
19. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
Deeks SL; Clark M; Scheifele DW; Law BJ; Dawar M; Ahmadipour N; Walop W; Ellis CE; King A
Pediatr Infect Dis J; 2005 Jun; 24(6):538-41. PubMed ID: 15933565
[TBL] [Abstract][Full Text] [Related]
20. Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana.
Yamoah P; Mensah KB; Padayachee N; Bangalee V; Oosthuizen F
Hum Vaccin Immunother; 2023 Dec; 19(1):2199654. PubMed ID: 37127290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
